Analysis of IgG4 class switch-related molecules in IgG4-related disease

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Tsuboi, Hiroto ^a   Matsuo, Naomi ^a   Iizuka, Mana ^a   Tsuzuki, Sayaka ^a   Kondo, Yuya ^a   Tanaka, Akihiko ^b   Moriyama, Masafumi ^b   Matsumoto, Isao ^a   Nakamura, Seiji ^b   Sumida, Takayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD20 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; IMMUNOGLOBULIN G4; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; PROTEIN; PROTEIN AID; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G;

ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; GENE REARRANGEMENT; GENETIC RECOMBINATION; HUMAN; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOPATHOLOGY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SJOEGREN SYNDROME; TH2 CELL; AGED; BIOSYNTHESIS; BLOOD; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PHYSIOLOGY; SJOGREN'S SYNDROME; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SJOGREN'S SYNDROME; YOUNG ADULT;

EID: 84864805507     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3924     Document Type: Article

References (17)

1. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Sumida T, Mimori T, Tanaka Y, Tsubota K, Yoshino T, Kawa S, Suzuki R, Takegami T, Tomosugi N, Kurose N, Ishigaki Y, Azumi A, Kojima M, Nakamura S, Inoue D. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012, 22:1-14. 10.1007/s10165-011-0508-6, 3278618, 21881964.
2. John HS, Yoh Z, Vikram D. IgG4-related disease. N Engl J Med 2012, 366:539-551. 10.1056/NEJMra1104650, 22316447.
3. Zen Y, Fujii T, Harada K, Kawano M, Yamada K, Takahira M, Nakanuma Y. Th2 and regulatory immune reaction are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007, 45:1538-1546. 10.1002/hep.21697, 17518371.
4. Miyake K, Moriyama M, Aizawa K, Nagano S, Inoue Y, Sadanaga A, Nakashima H, Nakamura S. Peripheral CD4+ T cells showing a Th2 phonotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol 2008, 18:86-90. 10.1007/s10165-007-0010-3, 18094933.
5. Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Maehara T, Shinozaki S, Kubo Y, Nakamura S. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz's disease. Arthritis Rheum 2012, 64:254-263. 10.1002/art.33320, 21898360.
6. Nakashima H, Miyake K, Moriyama M, Tanaka A, Watanabe M, Abe Y, Sato H, Nakamura S, Saito T. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol 2010, 73:385-391.
7. Akitake R, Watanabe T, Zaima C, Uza N, Ida H, Tada S, Nishida N, Chiba T. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 2010, 59:542-545. 10.1136/gut.2009.200972, 20332525.
8. Miyoshi H, Uchida K, Taniguchi T, Yazumi S, Matsushita M, Takaoka M, Okazaki K. Circulating naïve and CD4+CD25-high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008, 36:133-140. 10.1097/MPA.0b013e3181577553, 18376303.
9. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998, 160:3555-3561.
10. Reefer AJ, Carneiro RM, Custis NJ, Platts-Mills TA, Sung SS, Hammer J, Woodfolk JA. A role for IL-10-mediated HLA-DR7-restricted T cell dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004, 172:2763-2772.
11. Biernacka A, Dobaczewski M, Frangogiannis NG. TGF-β signaling in fibrosis. Growth Factors 2011, 29:196-202. 10.3109/08977194.2011.595714, 21740331.
12. Clifford MS, Kenneth BM, Piotr Z. The immunoglobulin class switch: beyond "Accessibility". Immunity 1997, 6:217-223. 10.1016/S1074-7613(00)80324-6, 9075922.
13. Avery DT, Bryant VL, Ma CS, Malefyt RW, Tangye SG. IL-21-induced isotype switching to IgG and IgA by human naïve B cells is differentially regulated by IL-4. J Immunol 2008, 181:1767-1779.
14. Arthur LS, NC Tolga E, Paul BR, Louis MS. IRF4: Immunity. Malignancy! Therapy?. Clin Cancer Res 2009, 15:2954-2961. 10.1158/1078-0432.CCR-08-1845, 2790720, 19383829.
15. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, Matsui S, Yoshino T, Nakamura S, Kawa S, Hamano H, Kamisawa T, Shimosegawa T, Shimatsu A, Nakamura S, Ito T, Notohara K, Sumida T, Tanaka Y, Mimori T, Chiba T, Mishima M, Hibi T, Tsubouchi H, Inui K, Ohara H. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012, 22:21-30. 10.1007/s10165-011-0571-z, 22218969.
16. Fujibayashi T, Sugai S, Miyasaka N, Hayashi Y, Tsubota K. Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol 2004, 14:425-434.
17. Gikas EK, Niki MM, Sharon MM. T lymphocytes in Sjögren's syndrome: contributors to and regulators of pathophysiology. Clin Rev Allerg Immunol 2007, 32:252-264.